YHYuzheng He

Yuzheng He

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuzheng He has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Baolei Lv

    Department of Thoracic Surgery, The First Hospital of Shijiazhuang, No. 36 Fanxi Road, Chang’an District, Shijiazhuang, Hebei, 050011, China

    2 shared publications
  • Fannian Li

    Department of Thoracic Surgery, The First Hospital of XingTai, No. 376 Shunde Road, XingTai, Hebei, 054001, China

    2 shared publications
  • Haitao Li

    Department of Pulmonary & Critical Care Medicine, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei, 050000, China

    2 shared publications
  • Helin Zhang

    Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei, 050000, China

    2 shared publications
  • Hongjiang Yan

    Department of Thoracic Surgery, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Shijiazhuang, Hebei, 050000, China

    2 shared publications
  • Junjie Shi

    Department of Thoracic Surgery, Handan First Hospital, No. 25 CongTai Road, HanDan, 056002, China

    2 shared publications

Latest Publications

  • miR-365a-5p Suppresses Gefitinib Resistance in Non-Small-Cell Lung Cancer through Targeting PELI3

    by Fannian Li, Haitao Li, Shuai Li, Baolei Lv, Junjie Shi, Hongjiang Yan, Helin Zhang, Yuzheng He

    Aim: Demonstrate the function of dysregulated miR-365a-5p-PELI3 signaling axis in the generation of gefitinib resistance during treatment for non-small-cell lung cancer (NSCLC). Patients & methods:...


  • Long Non-coding RNA MIAT Mediates Non-small Cell Lung Cancer Development Through Regulating the miR-128-3p/PELI3 Axis

    by Fannian Li, Haitao Li, Shuai Li, Baolei Lv, Junjie Shi, Hongjiang Yan, Helin Zhang, Yuzheng He

    In this study, we set out to characterize the expression status of long non-coding RNA (lncRNA) Myocardial Infarction Associated Transcript (MIAT) in non-small cell lung cancer (NSCLC) and elucidate its mechanistic contribution to this disease. Relative expression levels of MIAT, Pellino E3 Ubiquitin Protein Ligase Family Member 3 (PELI3), and microRNA (miR)-128-3p were analyzed by real-time polymerase chain reaction. PELI3 protein level was determined by immunoblotting. Cell viability and proliferation were evaluated by the MTT assay and colony formation assay, respectively. Cell invasion and migration were assessed by wound-healing closure and transwell assays, respectively. The regulatory actions of miR-128-3p on both MIAT and PELI3 were interrogated by luciferase reporter assay. We demonstrated the aberrant upregulation of MIAT in NSCLC and its association with tumor progression. We further uncovered the negative correlation among MIAT, PELI3, and miR-128-3p. MIAT deficiency significantly compromised cell viability, proliferation, invasion, and migration, while increased miR-128-3p and decreased PELI3 expressions. Application of miR-128-3p inhibitor significantly stimulated luciferase activities driven by both MIAT and PELI3 promoter and phenotypically promoted cell viability, proliferation, migration, and invasion. Our study highlighted the mechanistic contribution of the MIAT/miR-128-3p/PELI3 signaling cascade in NSCLC.


  • Open Access

    PELI3 mediates pro-tumor actions of down-regulated miR-365a-5p in non-small cell lung cancer

    by Yuzheng He, Yantao Shi, Ruilin Liu, Zhichao Wang, Baohua Wang, Shujun Li, Helin Zhang

    To analyze the relative expression of PELI3 and its mechanistic involvement in the non-small cell lung cancer (NSCLC). PELI3 expression in NSCLC tissue samples was determined by the immunohistochemistry. The transcripts abundance of PELI3 was measured with real-time PCR. The protein intensity was analyzed by western blot. The overall survival in respect to PELI3 or miR-365a-5p expression was plotted by the Kaplan–Meier’s analysis. Cell growth was determined by colony formation assay. Cell viability was measured by MTT assay. The migration and invasion were evaluated by wound healing and transwell assay respectively. The regulatory effect of miR-365a-5p on PELI3 was interrogated with luciferase reporter assay. The direct binding between miR-365a-5p and PELI3 was analyzed by pulldown assay. PELI3 was aberrantly up-regulated in NSCLC both in vivo and in vitro. High level of PELI3 associated with poor prognosis. PELI3-deficiency significantly inhibited cell viability, colony formation, migration and invasion. We further identified that miR-365a-5p negatively regulated PELI3 in this disease. Ectopic expression of miR-365a-5p in both A549 and H1299 phenocopied PELI3-deficiency. Meanwhile, PELI3-silencing significantly abolished the pro-tumoral effect elicited by miR-365a-5p inhibition. Our results highlighted the importance of dysregulated miR-365a-5p-PELI3 signaling axis in NSCLC.